CLINICAL TRIALS PROFILE FOR ZYNRELEF KIT
✉ Email this page to a colleague
All Clinical Trials for zynrelef kit
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05109312 ↗ | A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE | Recruiting | Heron Therapeutics | Phase 4 | 2021-10-18 | This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing different surgical procedures. Each parallel cohort will enroll subjects undergoing a unique surgical procedure: total shoulder arthroplasty (TSA) in Cohort 1 and abdominoplasty in Cohort 2. |
| NCT05188053 ↗ | Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty | Enrolling by invitation | Mayo Clinic | Phase 4 | 2022-01-01 | The purpose of this study is to compare an FDA-approved medication for post-operative pain control (HTX-011) to the standard of care institutional practice for periarticular analgesia after primary total knee arthroplasty (weight based dosing of Ropivacaine, epinephrine and ketorolac diluted with saline). We are doing this research study to find out if this new medication provides superior pain control within 72 hours following surgery. |
| NCT05644496 ↗ | ZYNRELEF for Pain Management in Total Knee Arthroplasty | Not yet recruiting | Baptist Health South Florida | Phase 4 | 2023-01-01 | The goal of this randomized controlled trial is to compare opioid medication consumption after surgery for patients who have a total knee replacement. The main questions it aims to answer are: - How well does the study drug control pain in the days after surgery? - Does the study drug reduce the amount of opioid analgesic consumed after surgery? Participants in the study group will undergo a total knee replacement as planned with their surgeon. In addition, be given the study drug, Zynrelef (combination of bupivacaine and meloxicam). Researchers will compare the above to a control group who will have a total knee replace only according to usual standards to see if there are any differences in the amount of a type of pain medication (opioid analgesic) consumed in the days following surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for zynrelef kit
Condition Name
Clinical Trial Locations for zynrelef kit
Trials by Country
Clinical Trial Progress for zynrelef kit
Clinical Trial Phase
Clinical Trial Sponsors for zynrelef kit
Sponsor Name
